Microbix Biosystems Inc. (MBXBF) Financials
MBXBF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 24.0 million | 6.9 million |
| March 31, 2026 | 25.4 million | 7.4 million |
| Dec. 31, 2025 | 26.7 million | 7.3 million |
| Sept. 30, 2025 | 26.9 million | 6.9 million |
MBXBF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -362405 | ? |
| March 31, 2026 | -381343 | 108316 |
| Dec. 31, 2025 | -2.0 million | 117090 |
| Sept. 30, 2025 | -50594 | 115288 |
MBXBF Net Income
No data available :(
MBXBF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 5.0 million | 3.8 million | 803715 |
| March 31, 2026 | 5.8 million | 3.3 million | 1.0 million |
| Dec. 31, 2025 | 6.6 million | 4.8 million | 1.1 million |
| Sept. 30, 2025 | 8.7 million | 3.8 million | 1.1 million |
MBXBF Shares Outstanding
MBXBF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 33701 | - | - | - |
| March 31, 2026 | 160064 | 432314 | 1.6 million | - |
| Dec. 31, 2025 | 124165 | 405993 | 1.5 million | - |
| Sept. 30, 2025 | 110972 | 450124 | 1.7 million | -634730 |
MBXBF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | 2.4 million | 1.3 million |
| Dec. 31, 2025 | 3.1 million | 1.8 million |
| Sept. 30, 2025 | 2.7 million | 1.6 million |
MBXBF
Price: $0.22
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.01 USD
P/E Ratio: -17.20
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 30.3 million